By physician referral or invitation only

InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients with End-Stage Renal Disease

Study to evaluate the safety and effectiveness of the InnAVasc Arteriovenous Graft (IG) for hemodialysis (HD) access in patients with end-stage renal disease (ESRD).

Age & Gender

18 years ~ 90 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Luigi Pascarella
Surgery - Vascular

Study Type

Clinical or Medical
Interventional

Study Topics

Kidneys and Liver

IRB Number

25-1284

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.